HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olga Dratviman-Storobinsky Selected Research

Lamin Type A (Lamin A)

7/2012C1824T mutation in the LMNA gene has no association with senile cataract.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olga Dratviman-Storobinsky Research Topics

Disease

2Ovarian Hyperstimulation Syndrome
11/2015 - 11/2014
2Hypoxia (Hypoxemia)
03/2012 - 09/2009
1COVID-19
01/2022
1Infections
01/2022
1Intellectual Disability (Idiocy)
01/2016
1Age-Related Nuclear Cataract
07/2012
1Cataract (Cataracts)
07/2012
1Progeria (Hutchinson Gilford Syndrome)
07/2012
1Premature Aging
07/2012
1Glioma (Gliomas)
01/2012
1Optic Nerve Injuries
12/2011
1Ganglion Cysts (Ganglion)
12/2011
1Thymoma (Thymic Carcinoma)
10/2011
1Ischemia
09/2011
1Retinal Artery Occlusion
09/2011
1Diabetic Retinopathy (Retinopathy, Diabetic)
09/2011
1Type 2 Diabetes Mellitus (MODY)
09/2011
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2011
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2011
1Melanoma (Melanoma, Malignant)
12/2010
1Melanosis (Freckles)
12/2010
1Neoplasm Metastasis (Metastasis)
12/2010
1Nevus (Nevi)
12/2010
1Uveal melanoma
12/2010
1Spontaneous Remission
11/2009
1Chemical Burns (Chemical Burn)
11/2009
1Corneal Neovascularization
11/2009
1Optic Nerve Diseases (Optic Neuropathy)
09/2009

Drug/Important Bio-Agent (IBA)

3Caspase 3 (Caspase-3)IBA
03/2012 - 01/2011
2Proteins (Proteins, Gene)FDA Link
11/2014 - 07/2012
2bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
12/2011 - 01/2011
2Retinaldehyde (Retinal)IBA
12/2011 - 09/2011
2Oxygen (Dioxygen)IBA
09/2011 - 01/2011
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2011 - 09/2009
2Neuroprotective AgentsIBA
01/2011 - 09/2009
1COVID-19 VaccinesIBA
01/2022
1VaccinesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1Prostaglandins DIBA
01/2016
1CytokinesIBA
11/2015
1Interleukin-2 (IL2)IBA
11/2014
1Capsules (Microcapsules)IBA
07/2012
1RNA Splice SitesIBA
07/2012
1LaminsIBA
07/2012
1Lamin Type A (Lamin A)IBA
07/2012
1Endoplasmic Reticulum Chaperone BiPIBA
03/2012
1Peptides (Polypeptides)IBA
03/2012
1Cytochromes c (Cytochrome c)IBA
03/2012
1Phosphatidylinositols (Phosphatidylinositol)IBA
10/2011
1HaptoglobinsIBA
09/2011
1Therapeutic UsesIBA
01/2011
1Codon (Codons)IBA
12/2010
1Bevacizumab (Avastin)FDA Link
11/2009
1Brimonidine Tartrate (Alphagan)FDA LinkGeneric
09/2009
1Heme (Haem)IBA
09/2009
1salicylhydroxamic acid (SHAM)IBA
09/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2009
1Superoxide Dismutase-1IBA
09/2009
1Glutathione Peroxidase GPX1IBA
09/2009
1Epidermal Growth Factor (EGF)IBA
09/2009
1pigment epithelium-derived factorIBA
09/2009

Therapy/Procedure

1Cataract Extraction
07/2012
1Therapeutics
01/2012
1Hyperbaric Oxygenation
01/2011
1Lasers (Laser)
12/2010
1Aftercare (After-Treatment)
11/2009